ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.24
-0.72 (-5.16%)
Jun 13, 2025, 4:08 PM HKT

HKG:1541 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
477.6306.98635.21668.33
Short-Term Investments
-42.5--
Trading Asset Securities
274.52259.09--
Cash & Short-Term Investments
752.12608.56635.21668.33
Cash Growth
23.59%-4.20%-4.96%-
Accounts Receivable
0.020.040.070.03
Other Receivables
0.171.040.960.02
Receivables
0.181.081.020.06
Inventory
24.5476.779.0419.42
Other Current Assets
91.090.296.5916.3
Total Current Assets
867.94686.7651.87704.1
Property, Plant & Equipment
47.71149.39163.89154.12
Other Long-Term Assets
6.3538.524.2234.62
Total Assets
922874.59839.98892.84
Accounts Payable
43.2410.81.261.76
Accrued Expenses
28.5930.8628.9124.17
Short-Term Debt
-59.98--
Current Portion of Long-Term Debt
100.89---
Current Portion of Leases
6.424.45.65.1
Current Income Taxes Payable
1.110.770.612.96
Current Unearned Revenue
32.9---
Other Current Liabilities
1.499.1115.362,444
Total Current Liabilities
214.64115.9151.742,478
Long-Term Debt
14.5---
Long-Term Leases
14.5510.49.0213.44
Total Liabilities
243.69126.360.762,491
Common Stock
407.31374.16356.096.91
Additional Paid-In Capital
1,093913.46654.47-
Retained Earnings
-1,026-710.35-330.89-1,638
Comprehensive Income & Other
205.21171.0199.5432.24
Total Common Equity
678.9748.29779.22-1,598
Minority Interest
-0.6---
Shareholders' Equity
678.31748.29779.22-1,598
Total Liabilities & Equity
922874.59839.98892.84
Total Debt
136.3674.7714.6218.54
Net Cash (Debt)
615.76533.79620.59649.79
Net Cash Growth
15.36%-13.99%-4.49%-
Net Cash Per Share
1.631.481.877.54
Filing Date Shares Outstanding
407.31374.16356.0986.18
Total Common Shares Outstanding
407.31374.16356.0986.18
Working Capital
653.3570.79600.13-1,774
Book Value Per Share
1.672.002.19-18.55
Tangible Book Value
678.9748.29779.22-1,598
Tangible Book Value Per Share
1.672.002.19-18.55
Machinery
52.8951.4449.9340.87
Construction In Progress
27.422.6922.463.22
Leasehold Improvements
22.4922.4922.4921.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.